Autopsy report · NCT02317276

A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

“Unable to meet the study's recruitment goals”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 4 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Dermatitis, Atopic

Interventions

Triamcinolone 0.1%

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• Tele-health Enabled Clinical Trial for COVID-19
  “Unable to overcome hurdles to study recruitment” (86% match in meaning)
• Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
  “Not enough study participants, difficulties in recruitment” (84% match in meaning)
• High-Dose Vitamin D Induction in Optic Neuritis
  “inability to meet recruitment goals” (83% match in meaning)
• TubeClear® Evaluation in Pediatric Patients (Phase I)
  “Unable to recruit; study determined not feasible to continue” (83% match in meaning)
• Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients
  “Unable to recruit into the study” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.